Eleven Therapeutics Corp

Encinitas, CA

UEI
E1W7Z1DEAH23
CAGE
86HE4
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
2228 Coolngreen Way, Encinitas, CA 92024, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Development of negative allosteric modulators of the MU-opioid receptor for the management of opioid use disorder R42DA056254 National Institute on Drug Abuse (NIH) $4,579,443
Development of negative allosteric modulators of the MU-opioid receptor for the management of opioid use disorder R41DA056254 National Institute on Drug Abuse (NIH) $640,000

Quick answers

Is Eleven Therapeutics Corp registered in SAM.gov?

Yes. Eleven Therapeutics Corp's SAM.gov registration is active through August 25, 2027.

What is Eleven Therapeutics Corp's most recent federal award?

Eleven Therapeutics Corp's most recent federal grant award is Development of negative allosteric modulators of the MU-opioid receptor for the management of opioid use disorder (R42DA056254), from National Institute on Drug Abuse (NIH), on August 1, 2022.

On GovTribe

See Eleven Therapeutics Corp's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login